Treace Medical Concepts (TMCI) Other financing activities (2020 - 2026)

Treace Medical Concepts (TMCI) reported Other financing activities of $6000.0 for Q1 2026, down 25.0% quarter-over-quarter from $8000.0 in Q1 2020.

Treace Medical Concepts (TMCI) Other financing activities (2020 - 2026) Analysis & Trends

Treace Medical Concepts has reported Other financing activities for 2 years, with the latest figure at $6000.0 in Q1 2026.

For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $6000.0; the trailing twelve-month figure through Mar 2026 stood at $6000.0 (changed N/A YoY), and the FY2025 full-year result was $1.2 million, changed N/A from the prior year.
Other financing activities for Q1 2026 stood at $6000.0, down from $8000.0 in the prior quarter.
The five-year high for Other financing activities was $6000.0 in Q1 2026, with the low at $6000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Treace Medical Concepts	274.20 Mn	222.34 Mn	37.41 Mn

Download Data